Tomorrow’s medicines, delivered Today...Where they’re needed the Most.
Access | Deliver | Impact
Clinician with patient Patient AI-enabled access technology Ring

Who we serve

Patients

We help you reach the treatment your doctor has identified.

If your doctor has recommended a medicine not yet approved in India, Sowaka manages the entire access process — legally, safely, and reliably. All support is coordinated through your treating physician.

Learn how we help patients →
HCP

Access critical medicines for your patients — before they are approved in India.

Named Patient and Early Access Programs for oncologists, specialists, and institutional pharmacy teams. Sowaka manages all regulatory paperwork, import logistics, and documentation.

See how we work with HCPs →
Pharma Company

End-to-end NPP and EAP infrastructure for pharma entering India.

From regulatory strategy to last-mile patient delivery — managed by Sowaka and powered by SowakaOS, our proprietary operating system for scaled access across underserved geographies.

Partner with Sowaka →
Sowaka Health
exists to reimagine the way the world accesses
life-saving medicines

Our capabilities : How We Deliver

Full-service pharmaceutical supply chain provider
Sourcing

Direct access to a panel of U.S. and EU national wholesalers and manufacturers.

Regulatory & Import

CDSCO navigation, NOC and import clearance, and full documentation.

Cold-Chain Storage

GDP-compliant storage and temperature-controlled handling.

Demand Generation

Physician and institution engagement to identify eligible patients.

Last-Mile & Direct-to-Patient

Compliant delivery to hospital or patient, with chain-of-custody confirmation.

Pharmacovigilance & Follow-up

Adverse-event intake and safety reporting. (Launching 2026.)

Why Healthcare Companies and physicians choose Sowaka

Combines global reach, local presence, and trusted technology to close the access gap of unregistered medicines in underserved countries

Sowaka Health Team

Global Access. Local Impact.

LICENSED & COMPLIANT

A US Wholesale Drug License and a CDSCO-compliant import model under Rule 36

FULLY INTEGRATED

Front-end and back-end operations owned by Sowaka

EXPANSIVE SOURCING

Direct access to U.S. and EU national wholesalers and manufacturers

DEEP PHARMA PEDIGREE

Founders with decades in pharmaceutical distribution and commercialization across Asia, the Middle East, Latin America and Africa

BUILT ON SOWAKAOS

A proprietary managed-access platform that turns every case into structured data

SowakaOS

Our proprietary managed-access operating system. Every request, order, filing, and delivery in one structured record — and the foundation of our real-world evidence capability.

Platform access and demo — coming in Phase 2.

Built on a regulatory-first foundation

CDSCO-compliant import model (Rule 36, Form 12A–12B)
US Wholesale Drug License
GDP-compliant cold chain
DPDP Act 2023 data protection
Pharmacovigilance & safety reporting — launching 2026